Stephen T. Worland, President and Chief Executive at eFFECTOR Therapeutics, Inc. (EFTR), bought 20,000 shares at $1.37 ($27K) on 2022-06-07, disclosed to the SEC on 2022-06-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ANDS | SELL | 2006-03-17 | $64K | — | Filing → |